These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31490625)

  • 1. Serum YKL40: A novel potential link between inflammation and dyslipidemia in acne vulgaris.
    Ebrahim A; Mustafa AI; El-Shimi OS; Fathy MA
    J Cosmet Dermatol; 2020 May; 19(5):1219-1223. PubMed ID: 31490625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children.
    Kwon Y; Kim JH; Ha EK; Jee HM; Baek HS; Han MY; Jeong SJ
    Mediators Inflamm; 2020; 2020():8713908. PubMed ID: 33061832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Effect of Oral Isotretinoin on the Level of Serum YKL40 in Acne Vulgaris Patients: A Cross-Sectional Case-Control.
    Ali MA; El Taieb MA; Hegazy EM; Ibrahim HM; Mohamed AA; Abdellatif MAA; Ahmed NM; Younis AM
    Clin Cosmet Investig Dermatol; 2023; 16():3241-3248. PubMed ID: 37965101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acne patients frequently associated with abnormal plasma lipid profile.
    Jiang H; Li CY; Zhou L; Lu B; Lin Y; Huang X; Wei B; Wang Q; Wang L; Lu J
    J Dermatol; 2015 Mar; 42(3):296-9. PubMed ID: 25639454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid profile in female patients with severe acne vulgaris.
    Arora MK; Seth S; Dayal S; Trehan AS; Seth M
    Clin Lab; 2014; 60(7):1201-5. PubMed ID: 25134390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum YKL-40 levels as a novel marker of inflammation and endothelial dysfunction in patients with pseudoexfoliation syndrome.
    Türkyılmaz K; Öner V; Kırbas A; Sevim MS; Sekeryapan B; Özgür G; Durmus M
    Eye (Lond); 2013 Jul; 27(7):854-9. PubMed ID: 23661157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-17 as a novel biomarker in patients with acne vulgaris.
    Ebrahim AA; Mustafa AI; El-Abd AM
    J Cosmet Dermatol; 2019 Dec; 18(6):1975-1979. PubMed ID: 30964235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy.
    Abu El-Hamd M; Adam El Taieb M; Mahmoud AA; Mahmoud Samy O
    J Dermatolog Treat; 2019 Sep; 30(6):545-548. PubMed ID: 30482111
    [No Abstract]   [Full Text] [Related]  

  • 10. Haplotype analysis and linkage disequilibrium of ApoB gene polymorphisms and its relationship with hyperlipidemia in patients with acne vulgaris.
    AbdElneam AI; Alhetheli G; Al-Dhubaibi MS; Bahaj SS
    J Gene Med; 2024 Jan; 26(1):e3578. PubMed ID: 37593849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment?
    Kutlu Ö
    Cutan Ocul Toxicol; 2020 Mar; 39(1):67-70. PubMed ID: 31809606
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyslipidemia and its association with meibomian gland dysfunction.
    Braich PS; Howard MK; Singh JS
    Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
    Pei Q; Sang WF; Zhao XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum desnutrin levels in patients with acne vulgaris.
    Demir B; Ucak H; Cicek D; Aydin S; Erden I; Dertlioglu SB
    Eur J Dermatol; 2014; 24(5):589-93. PubMed ID: 25152512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males.
    Peng K; Mo Z; Tian G
    Am J Med Sci; 2017 Mar; 353(3):236-241. PubMed ID: 28262209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
    Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
    J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
    Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
    In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of thyroid function and lipid profile in patients with postadolescent acne in a Mediterranean population from Turkey.
    Ekiz O; Balta I; Unlu E; Bulbul Sen B; Rifaioğlu EN; Dogramaci AC
    Int J Dermatol; 2015 Dec; 54(12):1376-81. PubMed ID: 25771990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum YKL-40 levels in patients with Kawasaki disease.
    Kim KY; Ahn Y; Kim DY; Kim HS; Kim DS
    Biomarkers; 2017; 22(3-4):326-330. PubMed ID: 27881022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.